Literature DB >> 17075984

Immunoproteome analysis of soluble and membrane proteins of Shigella flexneri 2457T.

Amy V Jennison1, Rubhana Raqib, Naresh K Verma.   

Abstract

AIM: To profile the immunogenic proteins of Shigella flexneri (S. flexneri) expressed during human infection using a proteomic approach.
METHODS: Soluble and membrane protein extractions of S. flexneri 2457T were separated by two-dimensional gel electrophoresis (2-DE). Proteins were transferred to PVDF membrane and immunoblotted with sera from shigellosis patients. Reactive protein spots were matched to Coomassie stained gels run in parallel, cut out and trypsin digested. Matrix-assisted laser desorption/ionization time of flight-mass spectrometry (MALDI-TOF-MS) was used to determine the peptide mass fingerprints, which were searched in the MASCOT database to identify the protein.
RESULTS: A total of 8 immunoreactive proteins were successfully identified from the Coomassie stained gels in three repeats. Six of these proteins have not previously been reported as immunogenic in S. flexneri. These proteins could be potential candidates for vaccine or attenuation studies.
CONCLUSION: Soluble and membrane proteins of S. flexneri 2457T have been screened by 2-DE and immunoblotting with sera from shigellosis patients. Eight proteins are identified as immunogenic.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17075984      PMCID: PMC4125676          DOI: 10.3748/wjg.v12.i41.6683

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  41 in total

1.  Spa33, a cell surface-associated subunit of the Mxi-Spa type III secretory pathway of Shigella flexneri, regulates Ipa protein traffic.

Authors:  R Schuch; A T Maurelli
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

2.  Probability-based protein identification by searching sequence databases using mass spectrometry data.

Authors:  D N Perkins; D J Pappin; D M Creasy; J S Cottrell
Journal:  Electrophoresis       Date:  1999-12       Impact factor: 3.535

3.  Identification of vaccine candidate antigens of Staphylococcus aureus by serological proteome analysis.

Authors:  Oresta Vytvytska; Eszter Nagy; Martin Blüggel; Helmut E Meyer; Robert Kurzbauer; Lukas A Huber; Christoph S Klade
Journal:  Proteomics       Date:  2002-05       Impact factor: 3.984

Review 4.  The Tol proteins of Escherichia coli and their involvement in the translocation of group A colicins.

Authors:  Jean-Claude Lazzaroni; Jean-François Dubuisson; Anne Vianney
Journal:  Biochimie       Date:  2002 May-Jun       Impact factor: 4.079

5.  Immunoproteome of Helicobacter pylori.

Authors:  Peter R Jungblut; Dirk Bumann
Journal:  Methods Enzymol       Date:  2002       Impact factor: 1.600

6.  Proteomic analysis of the Escherichia coli outer membrane.

Authors:  M P Molloy; B R Herbert; M B Slade; T Rabilloud; A S Nouwens; K L Williams; A A Gooley
Journal:  Eur J Biochem       Date:  2000-05

7.  Comprehensive detection of immunorelevant Borrelia garinii antigens by two-dimensional electrophoresis.

Authors:  P R Jungblut; G Grabher; G Stöffler
Journal:  Electrophoresis       Date:  1999-12       Impact factor: 3.535

8.  Analysis of the serologic response to systemic Candida albicans infection in a murine model.

Authors:  A Pitarch; R Díez-Orejas; G Molero; M Pardo; M Sánchez; C Gil; C Nombela
Journal:  Proteomics       Date:  2001-04       Impact factor: 3.984

9.  Multiple independent origins of Shigella clones of Escherichia coli and convergent evolution of many of their characteristics.

Authors:  G M Pupo; R Lan; P R Reeves
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

10.  Isolation and characterization of a Shigella flexneri invasin complex subunit vaccine.

Authors:  K R Turbyfill; A B Hartman; E V Oaks
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

View more
  7 in total

Review 1.  Secretome, surfome and immunome: emerging approaches for the discovery of new vaccine candidates against bacterial infections.

Authors:  Pratistha Dwivedi; Syed Imteyaz Alam; Rajesh Singh Tomar
Journal:  World J Microbiol Biotechnol       Date:  2016-07-27       Impact factor: 3.312

2.  The Shigella dysenteriae serotype 1 proteome, profiled in the host intestinal environment, reveals major metabolic modifications and increased expression of invasive proteins.

Authors:  Rembert Pieper; Quanshun Zhang; Prashanth P Parmar; Shih-Ting Huang; David J Clark; Hamid Alami; Arthur Donohue-Rolfe; Robert D Fleischmann; Scott N Peterson; Saul Tzipori
Journal:  Proteomics       Date:  2009-11       Impact factor: 3.984

3.  Outer membrane protein A (OmpA) of Shigella flexneri 2a, induces protective immune response in a mouse model.

Authors:  Debasis Pore; Nibedita Mahata; Amit Pal; Manoj K Chakrabarti
Journal:  PLoS One       Date:  2011-07-26       Impact factor: 3.240

4.  In vivo versus in vitro protein abundance analysis of Shigella dysenteriae type 1 reveals changes in the expression of proteins involved in virulence, stress and energy metabolism.

Authors:  Srilatha Kuntumalla; Quanshun Zhang; John C Braisted; Robert D Fleischmann; Scott N Peterson; Arthur Donohue-Rolfe; Saul Tzipori; Rembert Pieper
Journal:  BMC Microbiol       Date:  2011-06-24       Impact factor: 3.605

5.  The periplasmic enzyme, AnsB, of Shigella flexneri modulates bacterial adherence to host epithelial cells.

Authors:  Divya T George; Ulrike Mathesius; Carolyn A Behm; Naresh K Verma
Journal:  PLoS One       Date:  2014-04-24       Impact factor: 3.240

6.  Identification and evaluation of novel vaccine candidates against Shigella flexneri through reverse vaccinology approach.

Authors:  Abolfazl Hajialibeigi; Jafar Amani; Seyed Latif Mousavi Gargari
Journal:  Appl Microbiol Biotechnol       Date:  2021-01-16       Impact factor: 4.813

7.  Reverse vaccinology approach for the identification and characterization of outer membrane proteins of Shigella flexneri as potential cellular- and antibody-dependent vaccine candidates.

Authors:  Chiuan Yee Leow; Ada Kazi; Che Muhammad Khairul Hisyam Ismail; Candy Chuah; Boon Huat Lim; Chiuan Herng Leow; Kirnpal Kaur Banga Singh
Journal:  Clin Exp Vaccine Res       Date:  2020-01-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.